Diet beverages, or artificially-sweetened beverages (ASBs), became popular over the last few decades, largely due to successful marketing campaigns implying that consumption of these beverages would assist in weight control or weight loss. This review examines the existing evidence on the relationship between the consumption of diet beverages and the risk of obesity, diabetes, and cardiovascular disease. Findings from the review suggest that the presently available research on human epidemiologic and experimental studies on ASB intake and the risk for obesity and related chronic disease is lacking in rigor and consistency. The author concludes that based on the current scientific evidence, a blanket recommendation to either consume or avoid ASBs cannot be made.
Diet Beverages and the Risk of Obesity, Diabetes, and Cardiovascular Disease: A Review of the Evidence
Stories of Success: A Qualitative Examination of Contributors to Excellence in School Drinking Water Access
Drinking water instead of beverages with added sugar can help prevent obesity and cavities and promote overall health. Children spend much of their day in school, where they have variable access to drinking water. In 2010, federal and state law required California public schools to provide free potable water to … More
Policymakers worldwide are considering requiring warnings for sugary drinks. A growing number of experimental studies have examined sugary drink warnings’ impacts, but no research to our knowledge has synthesized this literature. To inform ongoing policy debates, this study aimed to identify the effects of sugary drink warnings compared with control … More
A Systematic Review of the Effectiveness of Promoting Water Intake to Reduce Sugar-sweetened Beverage Consumption
This study aimed to examine whether promotion of water intake in the general population in and of itself reduces sugar-sweetened beverage (SSB) consumption independent from interventions that target SSBs. Seven electronic databases were systematically searched: PubMed, Embase, PsycInfo, CINAHL Complete, Cochrane Central Register of Controlled Trials, CAB Direct, and Web … More